Elda Tagliabue

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 33

Top Venues

Cancers

International journal of molecular sciences

Cancer research

Cells

Fondazione IRCCS Istituto Nazionale dei Tumori

Fondazione IRCCS Istituto Nazionale dei Tumori (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori Jan 01 2009

Italy

Head of Molecular Targeting Unit :: Experimental Oncology and Molecular Medicine

Fondazione IRCCS Istituto Nazionale dei Tumori Jun 02 1985 - Dec 31 2008

Italy

Staff Researcher :: Experimental Oncology

Fondazione IRCCS Istituto Nazionale dei Tumori Jan 03 1983 - Jun 01 1985

Italy

Associate Researcher :: Experimental Oncology

Education History

Fondazione IRCCS Istituto Nazionale dei Tumori Oct 01 1979 - Dec 10 1982

Italy

PHD :: Experimental Oncology

Publications

Giancarla Bernardo, Valentino Le Noci, Martina Di Modica, Elena Montanari, Tiziana Triulzi, Serenella Maria Pupa, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini
The Emerging Role of the Microbiota in Breast Cancer Progression. Cells 12 (15) (2023)
Lorenzo Castagnoli, Simona Corso, Alma Franceschini, Alessandra Raimondi, Sara Erika Bellomo, Matteo Dugo, Federica Morano, Michele Prisciandaro, Silvia Brich, Antonino Belfiore, Andrea Vingiani, Maria Di Bartolomeo, Giancarlo Pruneri, Elda Tagliabue, Silvia Giordano, Filippo Pietrantonio, Serenella Maria Pupa
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer. Cellular oncology (Dordrecht) (2023)
Serena Indino, Cristina Borzi, Claudia Moscheni, Patrizia Sartori, Loris De Cecco, Giancarla Bernardo, Valentino Le Noci, Francesca Arnaboldi, Tiziana Triulzi, Gabriella Sozzi, Elda Tagliabue, Lucia Sfondrini, Nicoletta Gagliano, Massimo Moro, Michele Sommariva
The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. International journal of molecular sciences 23 (24) (2022)
Valentina Fogazzi, Marcel Kapahnke, Alessandra Cataldo, Ilaria Plantamura, Elda Tagliabue, Serena Di Cosimo, Giulia Cosentino, Marilena V Iorio
The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective. Cancers 14 (21) (2022)
Serena Indino, Cristina Borzi, Claudia Moscheni, Patrizia Sartori, Loris De Cecco, Giancarla Bernardo, Valentino Le Noci, Francesca Arnaboldi, Tiziana Triulzi, Gabriella Sozzi, Elda Tagliabue, Lucia Sfondrini, Nicoletta Gagliano, Massimo Moro, Michele Sommariva
The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. International journal of molecular sciences 23 (24) (2022)
Andrea Cairo, Marilena V Iorio, Silvia Spena, Elda Tagliabue, Flora Peyvandi
Worldwide SARS-CoV-2 haplotype distribution in early pandemic. PloS one 17 (2) (2022)
Milena Perrone, Claudia Chiodoni, Mara Lecchi, Laura Botti, Barbara Bassani, Annamaria Piva, Elena Jachetti, Matteo Milani, Daniele Lecis, Elda Tagliabue, Paolo Verderio, Sabina Sangaletti, Mario Paolo Colombo
ATF3 reprograms the bone marrow niche in response to early breast cancer transformation. Cancer research (2022)
Valentino Le Noci, Giancarla Bernardo, Giacomo Manenti, Gabriele Infante, Dariush Khaleghi Hashemian, Lucia Minoli, Simone Canesi, Francesca Bianchi, Tiziana Triulzi, Stefania Arioli, Loris De Cecco, Simone Guglielmetti, Federico Ambrogi, Camilla Recordati, Nicoletta Gagliano, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini
Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model. International journal of molecular sciences 23 (21) (2022)
Serena Indino, Cristina Borzi, Claudia Moscheni, Patrizia Sartori, Loris De Cecco, Giancarla Bernardo, Valentino Le Noci, Francesca Arnaboldi, Tiziana Triulzi, Gabriella Sozzi, Elda Tagliabue, Lucia Sfondrini, Nicoletta Gagliano, Massimo Moro, Michele Sommariva
The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. International journal of molecular sciences 23 (24) (2022)
Tiziana Triulzi, Viola Regondi, Elisabetta Venturelli, Patrizia Gasparini, Cristina Ghirelli, Jessica Groppelli, Martina Di Modica, Francesca Bianchi, Loris De Cecco, Lucia Sfondrini, Elda Tagliabue
HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer. Cancers 14 (22) (2022)
Simone Camelliti, Valentino Le Noci, Francesca Bianchi, Chiara Storti, Francesca Arnaboldi, Alessandra Cataldo, Serena Indino, Elena Jachetti, Alessandro Massimo Gianni, Mario Paolo Colombo, Andrea Balsari, Nicoletta Gagliano, Elda Tagliabue, Lucia Sfondrini, Michele Sommariva
Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain. Cancers 13 (16) (2021)
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, Marilena V Iorio, Alessandra Cataldo
Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers 13 (15) (2021)
Elda Tagliabue
Special Issue: Micro- and Macro-Environmental Factors in Solid Cancers. Cells 10 (2) (2021)
Martina Di Modica, Giorgio Gargari, Viola Regondi, Arianna Bonizzi, Stefania Arioli, Beatrice Belmonte, Loris De Cecco, Elena Fasano, Francesca Bianchi, Alessia Bertolotti, Claudio Tripodo, Laura Villani, Fabio Corsi, Simone Guglielmetti, Andrea Balsari, Tiziana Triulzi, Elda Tagliabue
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer. Cancer research 81 (8) (2021)
Ilona Rybinska, Nunzia Mangano, Elda Tagliabue, Tiziana Triulzi
Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences. International journal of molecular sciences 22 (7) (2021)
Sara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, Chiara Gargiuli, Loris De Cecco, Evandro de Azambuja, Debora Fumagalli, Christos Sotiriou, Nadia Harbeck, Miguel Izquierdo, Paolo G Nuciforo, Jens Huober, Vera Cappelletti, Saverio Cinieri, Martine Piccart, Maria Grazia Daidone, Giancarlo Pruneri, Mario Paolo Colombo, Elda Tagliabue, Paolo Verderio, Serena Di Cosimo
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Marta Giussani, Chiara Maura Ciniselli, Loris De Cecco, Mara Lecchi, Matteo Dugo, Chiara Gargiuli, Andrea Mariancini, Elisa Mancinelli, Giulia Cosentino, Silvia Veneroni, Biagio Paolini, Rosaria Orlandi, Massimiliano Gennaro, Marilena Valeria Iorio, Catherine Depretto, Claudio Ferranti, Gabriella Sozzi, Marialuisa Sensi, Mario Paolo Colombo, Gianfranco Scaperrotta, Elda Tagliabue, Paolo Verderio
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended. Cancers 13 (16) (2021)
Francesca Bianchi, Spyridon Alexiadis, Chiara Camisaschi, Mauro Truini, Giovanni Centonze, Massimo Milione, Andrea Balsari, Elda Tagliabue, Lucia Sfondrini
TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer. International journal of molecular sciences 21 (4) (2020)
Sandra L Romero-Córdoba, Ivan Salido-Guadarrama, María E Meneses, Giulia Cosentino, Marilena V Iorio, Elda Tagliabue, Nimbe Torres, Mónica Sánchez-Tapia, Myrna Bonilla, Ivan Castillo, Beatriz Petlacalco, Armando R Tovar, Daniel Martínez-Carrera
Mexican Ganoderma Lucidum Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet. Nutrients 13 (1) (2020)
Anna Rossini, Marta Giussani, Francesca Ripamonti, Piera Aiello, Viola Regondi, Andrea Balsari, Tiziana Triulzi, Elda Tagliabue
Combined targeting of EGFR and HER2 against prostate cancer stem cells. Cancer biology & therapy 21 (5) (2020)
Maria Teresa Majorini, Valeria Cancila, Alice Rigoni, Laura Botti, Matteo Dugo, Tiziana Triulzi, Loris De Cecco, Enrico Fontanella, Elena Jachetti, Elda Tagliabue, Claudia Chiodoni, Claudio Tripodo, Mario Paolo Colombo, Daniele Lecis
Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype. Cancer research 80 (11) (2020)
Lorenzo Castagnoli, Elda Tagliabue, Serenella Maria Pupa
Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness. International journal of molecular sciences 21 (23) (2020)
Michele Sommariva, Valentino Le Noci, Francesca Bianchi, Simone Camelliti, Andrea Balsari, Elda Tagliabue, Lucia Sfondrini
The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cellular and molecular life sciences : CMLS 77 (14) (2020)
Alessandra Cataldo, Sandra L Romero-Córdoba, Ilaria Plantamura, Giulia Cosentino, Alfredo Hidalgo-Miranda, Elda Tagliabue, Marilena V Iorio
MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer. Cancers 12 (8) (2020)
Ilona Rybinska, Marco Sandri, Francesca Bianchi, Rosaria Orlandi, Loris De Cecco, Patrizia Gasparini, Manuela Campiglio, Biagio Paolini, Lucia Sfondrini, Elda Tagliabue, Tiziana Triulzi
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment. Cells 9 (2) (2020)
Valentina Agnolon, Anna Contato, Anna Meneghello, Elda Tagliabue, Giuseppe Toffoli, Massimo Gion, Federico Polo, Aline S C Fabricio
ELISA assay employing epitope-specific monoclonal antibodies to quantify circulating HER2 with potential application in monitoring cancer patients undergoing therapy with trastuzumab. Scientific reports 10 (1) (2020)
Francesca Bianchi, Massimo Milione, Patrizia Casalini, Giovanni Centonze, Valentino M Le Noci, Chiara Storti, Spyridon Alexiadis, Mauro Truini, Gabriella Sozzi, Ugo Pastorino, Andrea Balsari, Elda Tagliabue, Lucia Sfondrini
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients. Scientific reports 9 (1) (2019)
Lorenzo Castagnoli, Michael Ladomery, Elda Tagliabue, Serenella Maria Pupa
The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers? Cancers 11 (7) (2019)
Valentino Le Noci, Michele Sommariva, Francesca Bianchi, Tiziana Triulzi, Elda Tagliabue, Andrea Balsari, Lucia Sfondrini
Local Administration of Caloric Restriction Mimetics to Promote the Immune Control of Lung Metastases. Journal of immunology research 2019 (2019)
Sandra L Romero-Córdoba, Elisabetta Meneghini, Milena Sant, Marilena Valeria Iorio, Lucia Sfondrini, Biagio Paolini, Roberto Agresti, Elda Tagliabue, Francesca Bianchi
Decoding Immune Heterogeneity of Triple Negative Breast Cancer and Its Association with Systemic Inflammation. Cancers 11 (7) (2019)
Tiziana Triulzi, Luca Forte, Viola Regondi, Martina Di Modica, Cristina Ghirelli, Maria Luisa Carcangiu, Lucia Sfondrini, Andrea Balsari, Elda Tagliabue
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy. Oncoimmunology 8 (1) (2018)
Francesca Bianchi, Samantha Pretto, Elda Tagliabue, Andrea Balsari, Lucia Sfondrini
Exploiting poly(I:C) to induce cancer cell apoptosis. Cancer biology & therapy 18 (10) (2017)
Martina Di Modica, Elda Tagliabue, Tiziana Triulzi
Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host. Disease markers 2017 (2017)

Elda Tagliabue.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elda Tagliabue